In a company update released earlier today, the Goldman Sachs Group, Inc. reiterated its Neutral rating for Vitamin Shoppe, Inc. VSI and raised its price target from $49.00 to $56.00.
Goldman Sachs said it made its decisions “as we hike our estimates on the flow-through of increased sales, and in addition we roll forward our risk/reward framework based on relative P/E. We also increase our Relative P/E multiples to reflect the enhanced trajectory of the business. The base-case multiple goes to 185% from 162% and the best-case multiple increases to 205% from 200%; our worst-case remains unchanged. Downside risks to our price target include moderating sector growth and regulatory risk; upside risks include a reacceleration in sales growth—driving multiple expansion.”
Vitamin Shoppe, Inc. closed yesterday at $51.61.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in